Estimates Revisions CASI Pharmaceuticals, Inc. Nasdaq

Stocks

Market Closed - Nasdaq Other stock markets 13:32:05 2026-07-17 EDT			5-day change	1st Jan Change
0.1660 ^USD	+8.30%		+14.40%	-80.47%

06-02	CASI Pharmaceuticals, Inc. Announces Resignation of Barbara Krebs-Pohl as Director, Effective May 31, 2026	CI
05-15	CASI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	ELI LILLY AND COMPANY
	JOHNSON & JOHNSON
	ABBVIE INC.
	ROCHE HOLDING AG
	NOVARTIS AG
	ASTRAZENECA PLC
	AMGEN INC.
	GILEAD SCIENCES, INC.
	PFIZER INC.
	Average
	Weighted average by Cap.